Dr. Lieff Interviewed by Boston Business Journal About New Alzheimer’s Medicine

N0021139 Illustration; the pathology of Alzheimer's Disease

The interview was based on Biogen’s presentation of the results of a phase I trial of a monoclonal antibody that works to eliminate amyloid. In a relatively small number of patients, the monoclonal antibody treatment lead to less amyloid and improved cognition. To read the interview in the Boston Business Journal, CLICK…

(Mehr in: Jon Lieff, M.D.)